Transvaginal Mesh Makers in the Hot Seat reports Life Care Solutions Group Several pharmaceutical giants are now the focus of major lawsuits over injuries caused by their vaginal mesh products
CONCORD, Calif., Dec. 27, 2013 /PRNewswire/ -- Women who have been injured by transvaginal mesh products are becoming increasingly aware of their legal options to recover compensation from makers of transvaginal mesh products. For years, the pain and suffering of patients who have been treated with these medical devices seemed like a well kept secret; however, since the initial release of information by the FDA in 2008 about the associated risks, more manufacturers of these products are finding themselves in hot water over the release of these dangerous devices into the market.
Implanted for the treatment of pelvic organ prolapse and stress urinary incontinence, transvaginal mesh implant surgery was once widely believed to be beneficial to provide support for weakened pelvic floor muscles. Even after the FDA's public health notification about reported complications suffered by thousands of women, many more continued to undergo transvaginal mesh surgical procedures without fully understanding the risks.
Transvaginal Mesh or Sling Products
"The Transvaginal Mesh, or Sling disaster may involve 10,000's of US women with severe injuries... According to the New York Times, in 2010, about 185,000 women underwent procedures in which mesh was implanted vaginally to treat urinary incontinence. That is 2010 alone."
For more information about transvaginal mesh or sling injuries, please visit http://usdrugwatchdog.com/transvaginal.htm
Again in 2011, the FDA released a communication citing several additional reports of health problems linked to POP and SUI mesh repairs.
FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse
In order to better understand the use of surgical mesh for POP and SUI, the FDA conducted a systematic review of the published scientific literature from 1996 – 2011 to evaluate its safety and effectiveness. The review showed that transvaginal POP repair with mesh does not improve symptomatic results or quality of life over traditional non-mesh repair. The FDA continues to evaluate the literature for SUI surgeries using surgical mesh and will report about that usage at a later date.
For more information about the FDA's update on complication associated with the surgical mesh, please visit http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm
Among the manufacturers named in lawsuits filed on behalf of injured vaginal mesh surgery patients are Johnson & Johnson, C.R. Bard, AMS, and Boston Scientific. Several victims have already won bellwether cases against the companies, and many more are pending.
The Life Care Solutions Group is available to help women who have been injured by a transvaginal mesh device and have questions about their medical and legal options. Those who need help can contact the group for more information today.
Greg A. Vigna
SOURCE Life Care 123 LLC